Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

RECRUITING

Identifier: CI-TRIAL-00101453
Entity page: /trial/NCT06357754 ↗
Edges: 5

Neighbours: 3 cancers2 drugs
Drawn: 5 of 5 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy condition of …CONDITION_OFderived3 of 3
← condition of	Chronic Lymphocytic Leukemia registry condition “Chronic Lymphocytic Leukaemia” mapped ONTOLOGY_EXACT	—	—	Chronic Lymphocytic Leukemia	1	Observed	clinicaltrials	graph →
← condition of	Multiple Myeloma registry condition “Multiple Myeloma” mapped CURATED_EXACT

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy intervention of …INTERVENTION_OFderived2 of 2
← intervention of	Idecabtagene Vicleucelgene therapy registry intervention “Idecabtagene vicleucel” (BIOLOGICAL) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Lisocabtagene Maraleucelgene therapy registry intervention “Lisocabtagene maraleucel” (BIOLOGICAL) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy intervention of …INTERVENTION_OFderived2 of 2

← intervention of

Idecabtagene Vicleucelgene therapy

registry intervention “Idecabtagene vicleucel” (BIOLOGICAL) mapped ALIAS

—

not mapped

Observed

clinicaltrials

graph →